Ingen Technologies, Inc. (IGNT)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Aug 13, 2025
Ingen Technologies Revenue
In the fiscal year ending May 31, 2015, Ingen Technologies had annual revenue of $13.57K with 1.14% growth. Ingen Technologies had revenue of $3.38K in the quarter ending May 31, 2012, a decrease of -67.86%.
Revenue
13.57K
Revenue Growth
-70.89%
P/S Ratio
n/a
Revenue / Employee
2.71K
Employees
5
Market Cap
n/a
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
May 31, 2015 | 13.57K | 153.00 | 1.14% |
May 31, 2012 | 13.41K | -30.96K | -69.77% |
May 31, 2011 | 44.37K | -84.55K | -65.58% |
May 31, 2010 | 128.92K | 118.52K | 1,139.47% |
May 31, 2009 | 10.40K | -242.09K | -95.88% |
May 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 221.55M |
Elite Pharmaceuticals | 105.45M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.09M |
Silence Therapeutics | 27.17M |
Global Cord Blood | 196.10M |